According to IMARC Group latest report titled “Digital Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, offers a comprehensive analysis of the industry, which comprises insights on digital therapeutics market share. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The market is currently witnessing strong growth. The global Digital Therapeutics Market to grow at a CAGR of 22% during 2021-2026.
Digital therapeutics (DTx) refers to the delivery of evidence-based therapeutic interventions to patients via high-quality software programs. It can be used as a standalone therapy or in conjunction with medications, devices, and other treatments to optimize patient care and health outcomes. DTx captures personalized physiological parameters, enhances the existing medical treatments, provides therapy solutions, reduces reliance on pharmaceuticals, etc. Consequently, it finds numerous applications in diagnosing various medical conditions, including diabetes, Alzheimer’s disease, asthma, gastrointestinal problems, chronic obstructive pulmonary disease, etc. Digital therapeutics is utilized by patients and healthcare providers across the globe.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/digital-therapeutics-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
The rising prevalence of chronic diseases is one of the key factors driving the digital therapeutics market. In line with this, the inflating need for controlling the costs of healthcare treatments is further catalyzing the market growth. Moreover, the elevating adoption of DTx in several neuroscience applications, such as in the treatment of attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), depression, schizophrenia, bipolar disease, etc., is acting as another significant growth-inducing factor. Besides this, the increasing internet penetration across countries and the growing digitalization of the healthcare sector are also augmenting the global market. Additionally, the launch of numerous favorable initiatives by pharmaceutical companies to help patients track and self-manage diseases is anticipated to fuel the digital therapeutics market over the forecasted period.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/digital-therapeutics-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- 2Morrow Inc.
- Canary Health Inc.
- Click Therapeutics Inc.
- Mango Health Inc.
- Noom Health Inc.
- Omada Health Inc.
- Pear Therapeutics, Inc.
- Propeller Health
- Teladoc Health Inc.
- Voluntis Inc.
- WellDoc Inc
Digital Therapeutics Market Segmentation:
Our report has categorized the market based on region, application and end use.
Breakup by Application:
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
Breakup by End Use:
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800